RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Activity

329 hedge funds and large institutions have $1.57B invested in Recursion Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 110 increasing their positions, 90 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
329
Holders Change
-4
Holders Change %
-1.2%
% of All Funds
4.41%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
57
Increased
110
Reduced
90
Closed
60
Calls
$55.7M
Puts
$41M
Net Calls
+$14.6M
Net Calls Change
+$8.08M

Top Buyers

1
BlackRock
BlackRock
New York
$144M
2
Vanguard Group
Vanguard Group
Pennsylvania
$183M
3
Geode Capital Management
Geode Capital Management
Massachusetts
$39.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$16.2M
5
First Trust Advisors
First Trust Advisors
Illinois
$9.51M

Top Sellers

1
State Street
State Street
Massachusetts
$56.6M
2
AIM
ARK Investment Management
Florida
$167M
3
UBS AM
UBS AM
Illinois
$23.4M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$172K
5
LCM
Laurion Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
First Trust Advisors
26
First Trust Advisors
Illinois
$9.51M +$4.29M +848,791 +82%
Bank of America
27
Bank of America
North Carolina
$6.98M +$475K +93,953 +7%
VAS
28
Vestmark Advisory Solutions
Massachusetts
$6.78M +$3.2M +632,900 +90%
Citadel Advisors
29
Citadel Advisors
Florida
$6.65M -$6.79M -1,341,159 -51%
NL
30
Nuveen LLC
North Carolina
$6.2M -$3.48M -686,962 -36%
Two Sigma Investments
31
Two Sigma Investments
New York
$5.91M +$76.8K +15,187 +1%
Barclays
32
Barclays
United Kingdom
$5.89M +$2.9M +573,683 +97%
JF
33
Jump Financial
Illinois
$5.83M +$2.83M +558,848 +94%
Goldman Sachs
34
Goldman Sachs
New York
$5.72M -$1.85M -364,645 -24%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$5.47M +$1.1M +217,979 +25%
CFM
36
Comprehensive Financial Management
California
$4.77M – – –
IEFM
37
IQ EQ Fund Management
Ireland
$4.61M +$2.65M +523,848 +135%
Millennium Management
38
Millennium Management
New York
$3.74M +$1.2M +237,300 +47%
Capital Fund Management (CFM)
39
Capital Fund Management (CFM)
France
$3.65M +$2.6M +513,258 +248%
LIP
40
Liontrust Investment Partners
United Kingdom
$3.55M +$543K +107,331 +18%
NFGH
41
Nan Fung Group Holdings
Hong Kong
$3.36M – – –
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$3.21M +$2.9M +572,497 +940%
XT
43
XTX Topco
Cayman Islands
$3.19M +$3.19M +631,206 New
PBPIA
44
Pivotal bioVenture Partners Investment Advisor
California
$3.01M – – –
Swiss National Bank
45
Swiss National Bank
Switzerland
$2.86M +$419K +82,900 +17%
HF
46
HRT Financial
New York
$2.75M +$2.75M +544,159 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$2.62M +$800K +158,080 +44%
VF
48
Virtu Financial
New York
$2.27M +$2.1M +415,056 +1,219%
CM
49
Caption Management
Oklahoma
$2.13M +$2.13M +420,801 New
Ensign Peak Advisors
50
Ensign Peak Advisors
Utah
$2.08M – – –
1
2
3 4 5